Home / Latest Reports / Hospital Acquired Infections Control Market

Hospital Acquired Infections Control Market By Product and End User - Global Industry Analysis & Forecast to 2027

Published On : November 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC111596

Request Sample Inquiry Before Buying Request for Customization Check Discount

Hospital Acquired Infections Control Market By Product Type (Low Temperature Sterilization Equipment, Disinfection Equipment, Heat Sterilization Equipment, Radiation Sterilization Equipment) End User (Ambulatory Surgical Centers, Diagnostic Laboratories, Hospitals, Medical Institutions, Clinics) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Hospital Acquired Infections Control Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. The worldwide hospital acquired infections control market is anticipated to observe strong development amid the conjecture time frame. The amount of hospital acquired diseases has brought about a surging demand for a different sterile unit in clinics where the tools and instruments are disinfected and reprocessed. There are random checks by the administrative authorities to guarantee the use of sanitized consumables and tools.

Drivers and Restraints

Financial improvement in rising economies alongside rising disposable income of patients would help the market guaranteeing future supportability. Developing foundation of healthcare and medical expense by the governments would empower establishment and use of complex medical devices, for example, endoscopes in medicinal organizations like clinics. This would build the interest for endoscope reprocessing devices, as these are equipped for sanitizing medicinal devices productively. Moreover, ascend in healthcare expense would energize endoscope reprocessing devices producers to enter the market.

Regional Insights

North America is anticipated to grow tremendously owing to developed healthcare infrastructure and supportive initiatives made by the government.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Olympus Corporation
  • Getinge Group
  • Belimed AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Alere Inc.
  • Cepheid Inc
  • Medivators Inc.
  • STERIS Plc.
  • Steelco S.P.A

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Hospital Acquired Infections Control Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)

·         Low Temperature Sterilization Equipment

·         Disinfection Equipment

·         Heat Sterilization Equipment

·         Radiation Sterilization Equipment

·         Hospital Acquired Infections Control Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

·         Ambulatory Surgical Centers

·         Diagnostic Laboratories

·         Hospitals

·         Medical Institutions

·         Clinics

·         Hospital Acquired Infections Control Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

·         North America

§  North America Hospital Acquired Infections Control Market, By Country

o    U.S. Hospital Acquired Infections Control Market

o    Canada Hospital Acquired Infections Control Market

o    Mexico Hospital Acquired Infections Control Market

·         Europe

§  Europe Hospital Acquired Infections Control Market, By Country

o    Germany Hospital Acquired Infections Control Market

o    UK Hospital Acquired Infections Control Market

o    France Hospital Acquired Infections Control Market

o    Russia Hospital Acquired Infections Control Market

o    Italy Hospital Acquired Infections Control Market

o    Rest of Europe Hospital Acquired Infections Control Market

·         Asia-Pacific

§  Asia-Pacific Hospital Acquired Infections Control Market, By Country

o    China Hospital Acquired Infections Control Market

o    Japan Hospital Acquired Infections Control Market

o    South Korea Hospital Acquired Infections Control Market

o    India Hospital Acquired Infections Control Market

o    Southeast Asia Hospital Acquired Infections Control Market

o    Rest of Asia-Pacific Hospital Acquired Infections Control Market

·         South America

§  South America Hospital Acquired Infections Control Market

o    Brazil Hospital Acquired Infections Control Market

o    Argentina Hospital Acquired Infections Control Market

o    Columbia Hospital Acquired Infections Control Market

o    Rest of South America Hospital Acquired Infections Control Market

·         Middle East and Africa

§  Middle East and Africa Hospital Acquired Infections Control Market

o    Saudi Arabia Hospital Acquired Infections Control Market

o    UAE Hospital Acquired Infections Control Market

o    Egypt Hospital Acquired Infections Control Market

o    Nigeria Hospital Acquired Infections Control Market

o    South Africa Hospital Acquired Infections Control Market

o    Rest of MEA Hospital Acquired Infections Control Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Hospital Acquired Infections Control Market, By Product Type

5.1.     Introduction

5.2.     Global Hospital Acquired Infections Control Revenue and Market Share by Product Type (2017-2027)

5.2.1.  Global Hospital Acquired Infections Control Revenue and Revenue Share by Product Type (2017-2027)

5.3.     Low Temperature Sterilization Equipment

5.3.1.  Global Low Temperature Sterilization Equipment Revenue and Growth Rate (2017-2027)

5.4.     Disinfection Equipment

5.4.1.  Global Disinfection Equipment Revenue and Growth Rate (2017-2027)

5.5.     Heat Sterilization Equipment

5.5.1.  Global Heat Sterilization Equipment Revenue and Growth Rate (2017-2027)

5.6.     Radiation Sterilization Equipment

5.6.1.  Global Radiation Sterilization Equipment Revenue and Growth Rate (2017-2027)

6.       Hospital Acquired Infections Control Market, By End User

6.1.     Introduction

6.2.     Global Hospital Acquired Infections Control Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Hospital Acquired Infections Control Revenue and Revenue Share by End User (2017-2027)

6.3.     Ambulatory Surgical Centers

6.3.1.  Global Ambulatory Surgical Centers Revenue and Growth Rate (2017-2027)

6.4.     Diagnostic Laboratories

6.4.1.  Global Diagnostic Laboratories Revenue and Growth Rate (2017-2027)

6.5.     Hospitals

6.5.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

6.6.     Medical Institutions

6.6.1.  Global Medical Institutions Revenue and Growth Rate (2017-2027)

6.7.     Clinics

6.7.1.  Global Clinics Revenue and Growth Rate (2017-2027)

7.       Hospital Acquired Infections Control Market, By Region

7.1.     Introduction

7.2.     Global Hospital Acquired Infections Control Revenue and Market Share by Regions

7.2.1.  Global Hospital Acquired Infections Control Revenue by Regions (2017-2027)

7.3.     North America Hospital Acquired Infections Control by Countries

7.3.1.  North America Hospital Acquired Infections Control Revenue and Growth Rate (2017-2027)

7.3.2.  North America Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Hospital Acquired Infections Control by Countries

7.4.1.  Europe Hospital Acquired Infections Control Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Hospital Acquired Infections Control by Countries

7.5.1.  Asia-Pacific Hospital Acquired Infections Control Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Hospital Acquired Infections Control by Countries

7.6.1.  South America Hospital Acquired Infections Control Revenue and Growth Rate (2017-2027)

7.6.2.  South America Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Hospital Acquired Infections Control by Countries

7.7.1.  Middle East and Africa Hospital Acquired Infections Control Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Olympus Corporation

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Getinge Group

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Belimed AG

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Pfizer Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Merck & Co., Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Abbott Laboratories

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Alere Inc.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Cepheid Inc

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     Medivators Inc.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. STERIS Plc.

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

8.11. Steelco S.P.A

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.       Revenue and Market Share

9.       Global Hospital Acquired Infections Control Market Competition, by Manufacturer

9.1.     Global Hospital Acquired Infections Control Revenue and Market Share by Manufacturer (2017-2017)

9.2.     Global Hospital Acquired Infections Control Price By Region (2017-2017)

9.3.     Top 5 Hospital Acquired Infections Control Manufacturer Market Share

9.4.     Market Competition Trend

10.    Hospital Acquired Infections Control Market Forecast (2017-2027)

10.1. Global Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Hospital Acquired Infections Control Market Forecast by Regions (2017-2027)

10.2.1.      North America Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.1.1. United States Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.1.2. Canada Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.1.3. Mexico Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.2.      Europe Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.2.1. Germany Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.2.2. France Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.2.3. UK Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.2.4. Russia Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.2.5. Italy Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.3.1. China Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.3.2. Japan Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.3.3. Korea Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.3.4. India Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.4.      South America Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.4.1. Brazil Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.4.2. Argentina Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.4.3. Columbia Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.4.4. Rest of South America Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.5.3. Egypt Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.5.4. Nigeria Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.5.5. South Africa Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.5.6. Turkey Hospital Acquired Infections Control Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Hospital Acquired Infections Control Market Forecast (2017-2027)

10.3. Hospital Acquired Infections Control Market Forecast by Product Type (2017-2027)

10.3.1.      Hospital Acquired Infections Control Forecast by Product Type (2017-2027)

10.3.2.      Hospital Acquired Infections Control Market Share Forecast by Product Type (2017-2027)

10.4. Hospital Acquired Infections Control Market Forecast by End User (2017-2027)

10.4.1.      Hospital Acquired Infections Control Forecast by End User (2017-2027)

10.4.2.      Hospital Acquired Infections Control Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Hospital Acquired Infections Control Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Hospital Acquired Infections Control Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Low Temperature Sterilization Equipment Revenue and Growth Rate (2017-2018)
Figure Global Disinfection Equipment Revenue and Growth Rate (2017-2018)
Figure Global Heat Sterilization Equipment Revenue and Growth Rate (2017-2018)
Figure Global Radiation Sterilization Equipment Revenue and Growth Rate (2017-2018)
Table Global Hospital Acquired Infections Control Revenue and Revenue Share by End User (2017-2018)
Figure Global Ambulatory Surgical Centers Revenue and Growth Rate (2017-2018)
Figure Global Diagnostic Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Medical Institutions Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Table Global Hospital Acquired Infections Control Revenue by Regions (2017-2018)
Figure North America Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure North America Hospital Acquired Infections Control Revenue and Growth Rate (2017-2018)
Figure North America Hospital Acquired Infections Control by Countries (2017-2018)
Figure North America Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2018)
Figure United States Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure United States Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Canada Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Mexico Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Europe Hospital Acquired Infections Control Revenue and Growth Rate (2017-2018)
Figure Europe Hospital Acquired Infections Control by Countries (2017-2018)
Figure Europe Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2018)
Figure Germany Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Germany Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure France Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure UK Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Russia Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Italy Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Rest of Europe Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Asia-Pacific Hospital Acquired Infections Control Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Hospital Acquired Infections Control by Countries (2017-2018)
Figure Asia-Pacific Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2018)
Figure China Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure China Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Japan Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Korea Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure India Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Southeast Asia Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure South America Hospital Acquired Infections Control Revenue and Growth Rate (2017-2018)
Figure South America Hospital Acquired Infections Control by Countries (2017-2018)
Figure South America Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Brazil Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Argentina Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Columbia Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Rest of South America Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Middle East and Africa Hospital Acquired Infections Control Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Hospital Acquired Infections Control by Countries (2017-2018)
Figure Middle East and Africa Hospital Acquired Infections Control Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Saudi Arabia Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure United Arab Emirates Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Egypt Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Nigeria Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure South Africa Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Turkey Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Hospital Acquired Infections Control Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2017-2018)
Table Olympus Corporation Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Getinge Group Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Belimed AG Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co., Inc. Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Alere Inc. Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cepheid Inc Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Medivators Inc. Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table STERIS Plc. Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Steelco S.P.A Hospital Acquired Infections Control Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Hospital Acquired Infections Control Market Share by Manufacturer
Figure Global Hospital Acquired Infections Control Revenue and Market Share by Manufacturer
Table Global Hospital Acquired Infections Control Price by Region (2017-2017)
Figure Top 5 Hospital Acquired Infections Control Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Hospital Acquired Infections Control Revenue (Millions USD) and Growth Rate (2018-2025)
Table Hospital Acquired Infections Control Market Forecast by Regions (2018-2025)
Figure North America Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure United States Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Canada Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Mexico Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Europe Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Germany Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure France Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure UK Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Russia Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Italy Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Rest of Europe Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Asia-Pacific Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure China Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Japan Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Korea Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure India Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Southeast Asia Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure South America Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Brazil Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Argentina Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Columbia Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Rest of South America Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Middle East and Africa Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Saudi Arabia Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure United Arab Emirates Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Egypt Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Nigeria Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure South Africa Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Turkey Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Hospital Acquired Infections Control Market Forecast (2018-2025)
Figure Global Hospital Acquired Infections Control Forecast by Product Type (2018-2025)
Figure Global Hospital Acquired Infections Control Market Share Forecast by Product Type (2018-2025)
Figure Global Hospital Acquired Infections Control Forecast by Product Type (2018-2025)
Figure Global Hospital Acquired Infections Control Forecast by End User (2018-2025)
Figure Global Hospital Acquired Infections Control Market Share Forecast by End User (2018-2025)
Figure Global Hospital Acquired Infections Control Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*